JP2024522692A5 - - Google Patents
Info
- Publication number
- JP2024522692A5 JP2024522692A5 JP2023577160A JP2023577160A JP2024522692A5 JP 2024522692 A5 JP2024522692 A5 JP 2024522692A5 JP 2023577160 A JP2023577160 A JP 2023577160A JP 2023577160 A JP2023577160 A JP 2023577160A JP 2024522692 A5 JP2024522692 A5 JP 2024522692A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- alkyl
- pharmaceutically acceptable
- acceptable salt
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163210204P | 2021-06-14 | 2021-06-14 | |
| US63/210,204 | 2021-06-14 | ||
| PCT/US2022/033334 WO2022266032A1 (en) | 2021-06-14 | 2022-06-14 | Cationic lipids and compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522692A JP2024522692A (ja) | 2024-06-21 |
| JP2024522692A5 true JP2024522692A5 (cg-RX-API-DMAC7.html) | 2025-06-24 |
Family
ID=82547431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577160A Pending JP2024522692A (ja) | 2021-06-14 | 2022-06-14 | カチオン性脂質及びその組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240293574A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4355727A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024522692A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240023420A (cg-RX-API-DMAC7.html) |
| CN (2) | CN117642380A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022291742A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3222589A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309145A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023014855A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022266032A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116082184B (zh) * | 2023-04-12 | 2023-06-30 | 山东大学 | 基于环己二胺的可电离脂质、脂质纳米颗粒及其制备方法与应用 |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025005632A1 (ko) * | 2023-06-26 | 2025-01-02 | 주식회사 무진메디 | 이온화 가능한 펩타이드를 이용한 지질 나노입자 기반 약물 전달체 및 이의 제조방법 |
| KR102898792B1 (ko) * | 2023-06-26 | 2025-12-19 | 주식회사 무진메디 | 이온화 가능한 펩타이드를 이용한 지질 나노입자 기반 약물 전달체 및 이의 제조방법 |
| AU2024413489A1 (en) * | 2023-12-29 | 2026-07-16 | Samyang Biopharm Corporation | Nanoparticle composition for drug delivery |
| CN117964577B (zh) * | 2024-03-29 | 2024-06-21 | 天津全和诚生物技术有限公司 | 阳离子脂质化合物、其制备方法、包含其的组合物及应用 |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| CN118634207B (zh) * | 2024-08-15 | 2024-11-26 | 北京悦康科创医药科技股份有限公司 | 一种雾化吸入用核酸-脂质纳米粒及其制备方法和应用 |
| CN118903476B (zh) * | 2024-10-10 | 2025-05-06 | 嘉晨西海(南昌)生物制药有限公司 | 含LNP和mRNA的组合物及其在治疗戈谢病中的应用 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| US5928906A (en) | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
| CA2289702C (en) | 1997-05-14 | 2008-02-19 | Inex Pharmaceuticals Corp. | High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| AU6814901A (en) | 2000-06-01 | 2001-12-11 | Univ North Carolina | Methods and compounds for controlled release of recombinant parvovirus vectors |
| WO2002087541A1 (en) | 2001-04-30 | 2002-11-07 | Protiva Biotherapeutics Inc. | Lipid-based formulations for gene transfer |
| EP1519714B1 (en) | 2002-06-28 | 2010-10-20 | Protiva Biotherapeutics Inc. | Method and apparatus for producing liposomes |
| CN1882693B (zh) | 2003-09-15 | 2012-08-15 | 普洛体维生物治疗公司 | 聚乙二醇修饰的脂质化合物及其应用 |
| US7404969B2 (en) | 2005-02-14 | 2008-07-29 | Sirna Therapeutics, Inc. | Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| JP5639338B2 (ja) | 2005-07-27 | 2014-12-10 | プロチバ バイオセラピューティクス インコーポレイティッド | リポソームの製造システムおよび製造方法 |
| WO2008103276A2 (en) | 2007-02-16 | 2008-08-28 | Merck & Co., Inc. | Compositions and methods for potentiated activity of biologicaly active molecules |
| EP3100718B1 (en) | 2008-01-02 | 2019-11-27 | Arbutus Biopharma Corporation | Improved compositions and methods for the delivery of nucleic acids |
| EP2279254B1 (en) | 2008-04-15 | 2017-07-05 | Protiva Biotherapeutics Inc. | Novel lipid formulations for nucleic acid delivery |
| EP3391877A1 (en) | 2010-04-08 | 2018-10-24 | The Trustees of Princeton University | Preparation of lipid nanoparticles |
| WO2011139911A2 (en) | 2010-04-29 | 2011-11-10 | Isis Pharmaceuticals, Inc. | Lipid formulated single stranded rna |
| US20120225129A1 (en) | 2010-08-20 | 2012-09-06 | Cerulean Pharma Inc. | Conjugates, particles, compositions, and related methods |
| CA2853689C (en) | 2011-11-04 | 2020-06-30 | Nitto Denko Corporation | Method of producing lipid nanoparticles for drug delivery |
| TWI595885B (zh) | 2012-05-02 | 2017-08-21 | 喜納製藥公司 | 包含四galnac之新穎結合物及傳送寡核苷酸之方法 |
| CN105085292B (zh) * | 2014-05-23 | 2017-12-15 | 上海交通大学 | 3‑((2‑(二甲氨基)乙烷基)(甲基)氨基)丙酸的两亲性衍生物及其用途 |
| HUE067372T2 (hu) | 2015-06-29 | 2024-10-28 | Acuitas Therapeutics Inc | Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására |
| HRP20220156T1 (hr) | 2015-09-17 | 2022-04-15 | Modernatx, Inc. | Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava |
| CN108368028B (zh) | 2015-10-28 | 2021-09-03 | 爱康泰生治疗公司 | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 |
| WO2017084987A1 (en) | 2015-11-16 | 2017-05-26 | F. Hoffmann-La Roche Ag | GalNAc CLUSTER PHOSPHORAMIDITE |
| DK3386484T3 (da) | 2015-12-10 | 2022-07-04 | Modernatx Inc | Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler |
| AU2017268396B2 (en) * | 2016-05-18 | 2023-05-18 | Modernatx, Inc. | Polynucleotides encoding citrin for the treatment of citrullinemia type 2 |
| RS63625B1 (sr) * | 2016-05-18 | 2022-10-31 | Modernatx Inc | Kombinacije irnk koje kodiraju imunomodulirajuće polipeptide i njihova upotreba |
| RS63953B1 (sr) * | 2017-03-15 | 2023-02-28 | Modernatx Inc | Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava |
| JP7630904B2 (ja) * | 2019-07-23 | 2025-02-18 | 株式会社東芝 | 核酸導入キャリア、核酸導入キャリアセット、核酸導入組成物及び核酸導入方法 |
| CN114929205B (zh) * | 2019-09-06 | 2024-09-03 | 世代生物公司 | 包括末端封闭式dna和可切割脂质的脂质纳米颗粒组合物及其使用方法 |
| WO2021092194A1 (en) * | 2019-11-05 | 2021-05-14 | Vicarious Surgical Inc. | Surgical virtual reality user interface |
| AU2020385378A1 (en) * | 2019-11-22 | 2022-04-07 | Generation Bio Co. | Ionizable lipids and nanoparticle compositions thereof |
| WO2022006368A2 (en) * | 2020-07-02 | 2022-01-06 | Life Technologies Corporation | Trinucleotide cap analogs, preparation and uses thereof |
| AU2021307952A1 (en) * | 2020-07-17 | 2023-03-02 | Generation Bio Co. | Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof |
-
2022
- 2022-06-14 CN CN202280049199.XA patent/CN117642380A/zh active Pending
- 2022-06-14 WO PCT/US2022/033334 patent/WO2022266032A1/en not_active Ceased
- 2022-06-14 US US18/569,623 patent/US20240293574A1/en active Pending
- 2022-06-14 CA CA3222589A patent/CA3222589A1/en active Pending
- 2022-06-14 AU AU2022291742A patent/AU2022291742A1/en active Pending
- 2022-06-14 KR KR1020247001308A patent/KR20240023420A/ko active Pending
- 2022-06-14 IL IL309145A patent/IL309145A/en unknown
- 2022-06-14 MX MX2023014855A patent/MX2023014855A/es unknown
- 2022-06-14 CN CN202610048440.7A patent/CN122079802A/zh active Pending
- 2022-06-14 JP JP2023577160A patent/JP2024522692A/ja active Pending
- 2022-06-14 EP EP22741620.3A patent/EP4355727A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023502576A5 (cg-RX-API-DMAC7.html) | ||
| JP2023518985A5 (cg-RX-API-DMAC7.html) | ||
| JP2024517644A5 (cg-RX-API-DMAC7.html) | ||
| JP2022546597A5 (cg-RX-API-DMAC7.html) | ||
| JP2023534043A5 (cg-RX-API-DMAC7.html) | ||
| US12252470B2 (en) | Lipids and nanoparticle compositions thereof | |
| KR20230052895A (ko) | 폴리뉴클레오타이드를 감소된 크기의 지질 나노입자로 캡슐화하는 방법 및 신규한 지질 나노입자 제형 | |
| JP2023527747A5 (cg-RX-API-DMAC7.html) | ||
| US20240293574A1 (en) | Cationic lipids and compositions thereof | |
| US20240226325A1 (en) | Cationic lipids and compositions thereof | |
| JP2024520756A5 (cg-RX-API-DMAC7.html) | ||
| US20230181764A1 (en) | Novel lipids and nanoparticle compositions thereof | |
| JP2024529343A5 (cg-RX-API-DMAC7.html) | ||
| RU2023129760A (ru) | Катионные липиды и их композиции | |
| RU2023135629A (ru) | Катионные липиды и их композиции |